P53 and DNA-dependent protein kinase catalytic subunit independently function in regulating actin damage-induced tetraploid G1 arrest

Experimental and Molecular Medicine

Volumn 44, Issue 3, 2012, Pages 236-240

  Chae, Hee Don ^a   Kim, So Youn ^a   Park, Sang Eun ^a   Kim, Jeongbin ^a   Shin, Deug Y ^a  

^a Dankook University College of Medicine   (South Korea)

Author keywords

Actin cytoskeleton; Ataxia telangiectasia mutated protein; DNA activated protein kinase; Pectenotoxin 2; Tumor suppressor protein p53

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ATM PROTEIN; CAFFEINE; DNA DEPENDENT PROTEIN KINASE; DOXORUBICIN; PROTEIN P53; SERINE 15; SERINE 20; SERINE 37; SERINE DERIVATIVE; UNCLASSIFIED DRUG; WORTMANNIN;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL SYNCHRONIZATION; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; DNA DAMAGE; ENZYME REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; KNOCKOUT GENE; MOLECULAR DYNAMICS; POLYPLOIDY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TETRAPLOIDY;

ATAXIA TELANGIECTASIA;

EID: 84859778970     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2012.44.3.018     Document Type: Article

References (28)

1. Amon A. The spindle checkpoint. Curr Opin Genet Dev 1999; 9:69-75
2. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001;12: 1315-1328
3. Ashcroft M, Kubbutat MH, Vousden KH. Regulation of p53 Function and Stability by Phosphorylation. Mol Cell Biol 1999;19:1751-1758
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-1501
5. Chae HD, Yun J, Bang YJ, Shin DY. Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 2004;23: 4084-4088
6. Chae HD, Choi TS, Kim BM, Jung JH, Bang YJ, Shin DY. Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors. Oncogene 2005;24:4813-4819
7. Chae HD, Kim BM, Yun UJ, Shin DY. Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage. Oncogene 2008;27:4115-4121
8. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998;12:2973-2983
9. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989;246:629-634
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53
11. Jordan M, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991;51: 2212-2222
12. Jordan M, Wendell K, Gardiner S, Derry W, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996;56:816-825
13. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, Choi TS, Shin DY. P53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001;20:5818-5825
14. Jung MS, Jin DH, Chae HD, Kang S, Kim SC, Bang YJ, Choi TS, Choi KS, Shin DY. Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J Biol Chem 2004;279:17765-17771
15. Kaufmann WK, Heffernan TP, Beaulieu LM, Doherty S, Frank AR, Zhou Y, Bryant MF, Zhou T, Luche DD, Nikolaishvili-Feinberg N, Simpson DA, Cordeiro-Stone M. Caffeine and human DNA metabolism: the magic and the mystery. Mutat Res 2003;532:85-102
16. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-7495
17. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998;18:1055-1064
18. Margolis RL. Tetraploidy and tumor development. Cancer Cell 2005;8:353-354
19. Margolis RL, Lohez OD, Andreassen PR. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 2003;88:673-683
20. Minn AJ, Boise LH, Thompson CB. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 1996;10: 2621-2631
21. Oren M. Regulation of the p53 tumor suppressor protein. J Biol Chem 1999;274:36031-36034
22. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res 2000;60:542-545
23. Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 1997;88:315-321
24. Rudner AD, Murray AW. The spindle assembly checkpoint. Curr Opin Cell Biol 1996;8:773-780
25. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999;59: 4375-4382
26. Stewart ZA, Pietenpol JA. Cell cycle checkpoints as therapeutic targets. J Mammary Gland Biol Neoplasia 1999; 4:389-400
27. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 1998;58: 3620-3626
28. Ui M, Okada T, Hazeki K, Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995;20:303-307